Cullinan Therapeutics (CGEM) Share-based Compensation (2021 - 2026)
Cullinan Therapeutics (CGEM) reported Share-based Compensation of $8.45 million for Q2 2026, down 14.6% from $9.89 million a year earlier but up 10.9% from the prior quarter.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Share-based Compensation (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cullinan Therapeutics' Share-based Compensation came in at $32.84 million, down 14.3% year-over-year; for FY2025, it was $36.04 million, down 4.7% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $37.82 million in FY2024 (+24.3%), $30.44 million in FY2023 (+8.9%), $27.96 million in FY2022 (+14.7%) and $24.38 million in FY2021 (+63.5%).
- Five-year quarterly Share-based Compensation spans a low of $4.56 million in Q3 2021 and a high of $12.15 million in Q4 2021.
- Year over year, Share-based Compensation has now declined in each of the last three quarters, with growth averaging 0.1% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q2 2022 (growth of 106.7%); the low point was Q4 2022 (a decline of 38.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.62 million (Q1 2026), $7.31 million (Q4 2025) and $9.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Cullinan Therapeutics | 961.97 Mn | 961.97 Mn | - | 8.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.45 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Dec 31, 2025 | 7.31 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 9.37 Mn |
| Dec 31, 2024 | 9.63 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Jun 30, 2024 | 10.53 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 7.52 Mn |
| Sep 30, 2023 | 7.74 Mn |
| Jun 30, 2023 | 7.92 Mn |
| Mar 31, 2023 | 7.26 Mn |
| Dec 31, 2022 | 7.51 Mn |
| Sep 30, 2022 | 5.27 Mn |
| Jun 30, 2022 | 8.61 Mn |
| Mar 31, 2022 | 6.57 Mn |
| Dec 31, 2021 | 12.15 Mn |
| Sep 30, 2021 | 4.56 Mn |
API Access
Cullinan Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CGEM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();